Growth plate chondrocyte maturation is regulated by basal intracellular calcium

Exp Cell Res. 2002 Jun 10;276(2):310-9. doi: 10.1006/excr.2002.5527.

Abstract

Among the cellular events that are associated with the process of endochondral ossification is an incremental increase in chondrocyte basal intracellular free Ca(2+) concentration ([Ca(2+)](i)) from 50 to 100 nM. To determine if this rise in [Ca(2+)](i) functionally participates in the maturational process of growth plate chondrocytes (GPCs), we examined its effect on several markers of hypertrophy, including annexin V, bone morphogenetic protein-6, type X collagen, and indian hedgehog. Expression of these genes was determined under conditions either where the Ca(2+) chelator EGTA was used to deplete extracellular Ca(2+) and lower [Ca(2+)](i) to < 50 nM or where the extracellular addition of 5 mM CaCl(2) was used to elevate [Ca(2+)](i) to > 100 nM. Although no effect on the expression of these genes was observed following treatment with 5 mM CaCl(2), 4 mM EGTA significantly inhibited their expression. This effect was recapitulated in sternal chondrocytes and was reversed following withdrawal of EGTA. Based on these findings, we hypothesized that the EGTA-induced suppression of these genes was mediated by a factor whose expression is responsive to changes in basal [Ca(2+)](i). Since EGTA mimicked the effect of parathyroid hormone-related peptide (PTHrP) on GPC maturation, we examined the effect of low [Ca(2+)](i) on PTHrP expression. Suggesting that low [Ca(2+)](i) suppression of hypertrophy was PTHrP-dependent in GPCs, (a) treatment with 4 mM EGTA increased PTHrP expression, (b) the EGTA effect was rescued by blocking PTHrP binding to its receptor with the competitive antagonist TIP(7-39), and (c) EGTA could mimic the PTHrP stimulation of AP-1 binding to DNA. Additionally, PTHrP promoter analysis identified a domain (-1498 to -862, relative to the start codon) involved with conferring Ca(2+) sensitivity to the PTHrP gene. These findings underscore the importance of cellular Ca(2+) in GPC function and suggest that PTHrP action in the growth plate is at least partially regulated by changes in basal [Ca(2+)](i).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Animals, Newborn
  • Annexin A5 / genetics
  • Annexin A5 / metabolism
  • Bone Morphogenetic Protein 6
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / metabolism
  • Calcium / deficiency*
  • Calcium Signaling / drug effects
  • Calcium Signaling / genetics*
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics*
  • Cells, Cultured
  • Chelating Agents
  • Chick Embryo
  • Chickens
  • Chondrocytes / cytology
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism*
  • Collagen Type X / genetics
  • Collagen Type X / metabolism
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / genetics*
  • Growth Plate / embryology*
  • Growth Plate / growth & development
  • Growth Plate / metabolism
  • Hedgehog Proteins
  • Hypertrophy / genetics
  • Hypertrophy / metabolism
  • Intracellular Fluid / metabolism*
  • Osteogenesis / genetics*
  • Parathyroid Hormone-Related Protein
  • Proteins / drug effects
  • Proteins / genetics
  • Proteins / metabolism
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Transcription Factor AP-1 / drug effects
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Annexin A5
  • Bone Morphogenetic Protein 6
  • Bone Morphogenetic Proteins
  • Chelating Agents
  • Collagen Type X
  • Hedgehog Proteins
  • Parathyroid Hormone-Related Protein
  • Proteins
  • Trans-Activators
  • Transcription Factor AP-1
  • Calcium